MSB 2.51% 97.0¢ mesoblast limited

Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-357

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.